drugset / Trial / NCT06739551

Systemic Treatment Options for Generalized Lichen Planus

NCT06739551

Phase 2 Not yet recruiting 124 enrolled Sheikh Zayed Medical College
RandomizedParallel-groupOpen-labelTreatment

Summary

Lichen planus is a chronic inflammatory skin condition with unknown etiology. It requires a long term treatment. Evaulating the most efficacious, safe and affordable treatment option is the need of the hour. This study is going to compare the efficacy of two familiar drugs (acitretin and methotrexate) in the treatment of generalized lichen planus as to find out the relatively more effective and safer treatment.

Timeline

Start
2024-12-10
Primary completion
2025-03-15
Completion
2025-03-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acitretin Small molecule 50 mg Oral
Comparator Methotrexate Small molecule 10 mg Oral

Indications